Shatakshee Chatterjee1, Rohan Chaubal2, Arindam Maitra1, Nilesh Gardi2, Amit Dutt2, Sudeep Gupta3,4, Rajendra A Badwe5,6, Partha P Majumder7, Priyanka Pandey8. 1. National Institute of Biomedical Genomics, P.O.: N.S.S., Kalyani, 741251, West Bengal, India. 2. Tata Memorial Centre/Hospital, Parel, Mumbai, 400012, India. 3. Tata Memorial Centre/Hospital, Parel, Mumbai, 400012, India. sudeep.gupta@actrec.gov.in. 4. Department of Medical Oncology, Tata Memorial Centre, Mumbai, 400012, India. sudeep.gupta@actrec.gov.in. 5. Tata Memorial Centre/Hospital, Parel, Mumbai, 400012, India. badwera@tmc.gov.in. 6. Department of Surgical Oncology, Tata Memorial Centre, Mumbai, 400012, India. badwera@tmc.gov.in. 7. National Institute of Biomedical Genomics, P.O.: N.S.S., Kalyani, 741251, West Bengal, India. ppm1@nibmg.ac.in. 8. National Institute of Biomedical Genomics, P.O.: N.S.S., Kalyani, 741251, West Bengal, India. pp1@nibmg.ac.in.
Abstract
PURPOSE: We have reported a survival benefit of single injection of hydroxyprogesterone prior to surgery for primary tumour in patients with node-positive operable breast cancer. Hydroxyprogesterone was meant to recapitulate the luteal phase of menstrual cycle in these women. We wanted to understand the molecular basis of action of hydroxyprogesterone on primary breast tumours in a peri-operative setting. METHODS: We performed whole transcriptome sequencing (RNA-Seq) of primary breast tumour samples collected from patients before and after hydroxyprogesterone exposure and controls. Paired breast cancer samples were obtained from patients who were given hydroxyprogesterone before surgery and a group of patients who were subjected to only surgery. RESULTS: A test of significance between the two groups revealed 207 significantly altered genes, after correction for multiple hypothesis testing. We found significantly contrasting gene expression patterns in exposed versus unexposed groups; 142 genes were up-regulated post-surgery among exposed patients, and down-regulated post-surgery among unexposed patients. Significantly enriched pathways included genes that respond to progesterone, cellular stress, nonsense-mediated decay of proteins and negative regulation of inflammatory response. These results suggest that cellular stress is modulated by hydroxyprogesterone. Network analysis revealed that UBC, a mediator of stress response, to be a major node to which many of the significantly altered genes connect. CONCLUSIONS: Our study suggests that pre-operative exposure to progesterone favourably modulates the effect of surgical stress, and this might underlie its beneficial effect when administered prior to surgery.
PURPOSE: We have reported a survival benefit of single injection of hydroxyprogesterone prior to surgery for primary tumour in patients with node-positive operable breast cancer. Hydroxyprogesterone was meant to recapitulate the luteal phase of menstrual cycle in these women. We wanted to understand the molecular basis of action of hydroxyprogesterone on primary breast tumours in a peri-operative setting. METHODS: We performed whole transcriptome sequencing (RNA-Seq) of primary breast tumour samples collected from patients before and after hydroxyprogesterone exposure and controls. Paired breast cancer samples were obtained from patients who were given hydroxyprogesterone before surgery and a group of patients who were subjected to only surgery. RESULTS: A test of significance between the two groups revealed 207 significantly altered genes, after correction for multiple hypothesis testing. We found significantly contrasting gene expression patterns in exposed versus unexposed groups; 142 genes were up-regulated post-surgery among exposed patients, and down-regulated post-surgery among unexposed patients. Significantly enriched pathways included genes that respond to progesterone, cellular stress, nonsense-mediated decay of proteins and negative regulation of inflammatory response. These results suggest that cellular stress is modulated by hydroxyprogesterone. Network analysis revealed that UBC, a mediator of stress response, to be a major node to which many of the significantly altered genes connect. CONCLUSIONS: Our study suggests that pre-operative exposure to progesterone favourably modulates the effect of surgical stress, and this might underlie its beneficial effect when administered prior to surgery.
Entities:
Keywords:
Hydroxyprogesterone; Network analysis; Operable breast cancer; RNA-Seq